Alnylam Pharmaceuticals (ALNY) Q1 2018 Earnings

8FebConfirmed
Q2 2017
Q3 2017
Q4 2017
Q1 2018
-1.48
-1.37
-1.27
-1.16

Details

Expected EPS
-1.39
Actual EPS
-1.48
Surprise EPS
-0.09
Surprise Percent
+6.47%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.48 per share for Q1 2018.

0 Comments

Share your thoughts